Obstetrics/Gynecology

Medicine & Life Sciences

1. Cricetinae 100%
2. Corpus Luteum 86%
3. Ovary 77%
4. Granulosa Cells 58%
5. Follicle Stimulating Hormone 53%
6. Dinoprost 44%
7. Luteal Cells 44%
8. Cattle 41%
9. Luteolysis 41%
10. Transforming Growth Factors 36%
11. Messenger RNA 35%
12. Ovarian Neoplasms 34%
13. Epidermal Growth Factor 33%
14. Progesterone 31%
15. Oocytes 30%
16. Pregnancy 30%
17. Gonadotropins 29%
18. Cervical Ripening 27%
19. In Vitro Techniques 22%
20. Guidelines 21%
21. Cell-Free Nucleic Acids 21%
22. Dinoprostone 21%
23. Uterine Neoplasms 21%
24. Proteins 20%
25. Luteinizing Hormone 20%
26. Estradiol 19%
27. Endothelial Cells 19%
28. Antral 19%
29. Uterine Cervical Neoplasms 19%
30. Mothers 19%
31. Fertility 19%
32. Hormones 17%
33. Granulosa Cell Tumor 17%
34. Growth Factor Receptors 17%
35. Estrous Cycle 17%
36. Practice Guidelines 17%
37. DNA 16%
38. Estrogens 16%
39. Neoplasms 16%
40. Fetus 15%
41. Steroids 15%
42. RNA 15%
43. Apoptosis 14%
44. Thioredoxins 14%
45. Cell Proliferation 14%
46. Activating Transcription Factor 3 14%
47. G-Protein-Coupled Receptors 13%
48. Pessaries 13%
49. Growth 13%
50. Ovarian Reserve 12%
51. Therapeutics 12%
52. Sarcoma 12%
53. Phosphorylation 12%
54. Thioredoxin-Disulfide Reductase 12%
55. Theca Cells 11%
56. Equipment and Supplies 11%
57. Gels 11%
58. Cervix Uteri 11%
59. Genes 11%
60. Adenocarcinoma 10%
61. Human Follicle Stimulating Hormone 10%
62. Endometrium 10%
63. Fetal Movement 10%
64. Obstetrics 10%
65. Growth Differentiation Factor 9 9%
66. Estrogen Receptors 9%
67. Fentanyl 9%
68. Glucose 9%
69. Mitogen-Activated Protein Kinases 9%
70. Glutaredoxins 9%
71. Sri Lanka 9%
72. Uterus 8%
73. Umbilical Arteries 8%
74. Oxidative Stress 8%
75. deslorelin 8%
76. FSH Receptors 8%
77. Hypoglycemic Agents 8%
78. Glycogen Synthase Kinase 3 7%
79. Serum 7%
80. TOR Serine-Threonine Kinases 7%
81. Transgender Persons 7%
82. Glyceraldehyde-3-Phosphate Dehydrogenases 7%
83. Sirolimus 7%
84. Bone Morphogenetic Protein 2 7%
85. Ovarian Follicle 7%
86. Follicular Fluid 7%
87. Antibodies 7%
88. Circulating Neoplastic Cells 7%
89. Cholesterol Side-Chain Cleavage Enzyme 7%
90. Breast Neoplasms 7%
91. Egypt 7%
92. Gonadotropin-Releasing Hormone 7%
93. Chemokine CCL2 7%
94. Major Histocompatibility Complex 7%
95. Sertoli Cells 7%
96. Polymerase Chain Reaction 6%
97. Extracellular Vesicles 6%
98. Blood Flow Velocity 6%
99. Ovarian Epithelial Carcinoma 6%
100. Ovulation Induction 6%